Multidrug-resistant tuberculosis (MDR-TB) in India: an attempt to link biosocial determinants.
Multidrug-resistant tuberculosis (MDR-TB) has emerged as a possible threat to global tuberculosis control efforts in recent years. It is a challenge not only from a public health point of view but also in the context of global economy, especially in the absence of treatment for MDR-TB at national-level programs in developing countries. Biological accounts are insufficient to understand the emergence and dynamics of drug resistance. This article focuses essentially on the need for a holistic perspective, linking biosocial determinants that would probably lead to better insights into MDR-TB control strategies.
Atre
Sachin R
SR
The Foundation for Research in Community Health, Aundh, Pune 411 007, Maharashtra, India.
Mistry
Nerges F
NF
D000995:Antitubercular Agents / Q000494:pharmacology; D003695:Delivery of Health Care; D004345:Drug Industry; D024881:Drug Resistance, Bacterial / Q000235:genetics; D014943:Global Health; D006291:Health Policy; D006801:Humans; D007194:India / Q000453:epidemiology; D017720:Molecular Epidemiology; D011203:Poverty; D015995:Prevalence; D012307:Risk Factors; D012737:Sex Factors; D012959:Socioeconomic Factors; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*
D000995:Antitubercular Agents